Why Vioxx, but not Other Drugs in Its Class, May Increase Cardiovascular Risk
Comforting news for Pfizer.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
More in Uncategorized
Past Week
-
What happened to real care in health care?
-
Pope Francis dies at 88. What his care reveals about America’s failing hospitals.
-
How doctors can thrive despite declining reimbursements
-
Buying into a medical practice: key legal and financial checks for physicians [PODCAST]
-
How DrKoop.com rose and fell: the untold story behind the Surgeon General’s startup
-
A surgeon’s startling ketamine experience [PODCAST]
-
Past 6 Months
-
How trade wars could destroy the U.S. health care system
-
The hidden bias young female physicians face every day
-
How hospitals are quietly taking control of physicians
-
How to advocate for your transgender child’s health care
-
Doctors don’t need yoga, they need time to smoke
-
How the system hunts physicians who refuse to kneel
-
Recent Posts
-
Buying into a medical practice: key legal and financial checks for physicians [PODCAST]
-
Why Medicaid is failing Black children despite record spending
-
When a friend’s mother became my patient and changed my life
-
Why ADHD isn’t just a childhood disorder and what that means for adults
-
Customer relationship management tools to beat physician burnout and regain practice control [PODCAST]
-
Rural hospitals are vanishing—and lives are vanishing with them
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
